ערך בספרים למניה: AtriCure (ATRC)

AtriCure, Inc. (ATRC) production of cardiac surgery devices is based on automated lines featuring visual quality control systems, although the implementation of new products requires the involvement of specialized experts. High demand for ablation systems to combat arrhythmia facilitates the company's expansion in the global market. The asset's price trajectory on GURU.Markets, where the indicator stands at 10.24, is subject to the influence of logistical disruptions and US trade restrictions.

Inelastic demand for AtriCure, Inc. (ATRC) cardiac procedures ensures a steady capital inflow. The book value per share is calculated by dividing the company's total equity by the number of outstanding securities. This indicator determines the net asset value per share. The stability of the curve confirms high operating margins and the business's defensive qualities. The growing trend enhances the issuer's fundamental attractiveness.